Alamar Biosciences, Inc. (ALMR) Net Margin
- 2026-06-30: Net Margin -44.85%.
- 2026-03-31: Net Margin -81.91%.
- 2025-06-30: Net Margin -43.45%.
- 2025-03-31: Net Margin -58.51%.
Complete source-backed net margin history.
- Available history
- 2025-03-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -44.85% |
| 2026-03-31 | -81.91% |
| 2025-06-30 | -43.45% |
| 2025-03-31 | -58.51% |
Annual Net Margin
| Date | Net Margin |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |